Skip to main content
SpringerLink
Log in

Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Idiopathic portal hypertension (IPH) is characterized by non-cirrhotic presinusoidal intrahepatic portal hypertension. The etiopathogenesis of the disease is poorly understood. Obliteration with microthrombosis of the small portal vein branches may lead to lesions underlying portal hypertension. We aimed to put forward a comprehensive thrombophilic mutation profile in IPH and its probable contribution to pathogenesis. Eleven patients and 12 controls were included. We used the CVD-StripAssay which is based on the reverse-hybridization principle to identify a total of 12 thrombophilic gene mutations: Factor V R506Q, Factor V H1299R, prothrombin G20210A, Factor XIII V34L, beta-Fibrinogen -455 G-A, PAI-1 4G/5G, platelet GPIIIa L33P, MTHFR C677T, MTHFR A1298C, ACE I/D, Apo B R3500Q and Apo E2/E3/E4, respectively. We also evaluated some blood parameters and protein C, protein S, AT-III levels using commercially available assays. IPH patients and controls were similar in respect to gender distribution (P = 1.000). Mean age was 31.2 in patients and 29.1 in controls (P = 0.622). Pica history was present in 54.5% of the patients. Mean protein C and AT-III levels were lower in patients than that of controls (P = 0.002 and 0.001, respectively). Factor XIII V34L, PAI-1, GPIIIa L33P, MTHFR C677T and MTHFR A1298C frequencies of genetic polymorphisms were found to be significantly higher among patients than that of controls. Apolipoprotein E2/E3/E4 analysis showed an inverse relationship with IPH when E2 plus E4 compared with E3. A higher frequency of Beta-Fibrinogen -455G-A mutation was observed in patients, but this difference did not reach a statistical significance. Our data represent the most comprehensive study to date with respect to thrombophilic gene polymorphisms in IPH. The data support a possible pathogenetic role in IPH, at least by some of the prothrombotic mutations. In order to confirm or refuse this proposal, a larger cohort of patients is needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Boyer JL, Sen Gupta KP, Biswas SK et al (1967) Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med 66:41–68

    PubMed  CAS  Google Scholar 

  2. Sama SK, Bhargava S, Nath NG et al (1971) Non-cirrhotic portal fibrosis. Am J Med 51:160–171

    Article  PubMed  CAS  Google Scholar 

  3. Levison DA, Kingham JG, Dawson AM et al (1982) Slow cirrhosis or no cirrhosis? A lesion causing benign intrahepatic portal hypertension. J Hepatol 137:253–272

    CAS  Google Scholar 

  4. Wanless IE (1990) Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 11:787–797

    Article  PubMed  CAS  Google Scholar 

  5. Mikkelsen WP, Edmondson HA, Peters RL et al (1965) Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg 162:602–608

    PubMed  CAS  Google Scholar 

  6. Sciot R, Staessen D, Van Damme B et al (1988) Incomplete septal cirrhosis: histopathological aspects. Histopathology 13:593–603

    PubMed  CAS  Google Scholar 

  7. Halllenbeck GA, Adson MA (1961) Esophagogastric varices without hepatic cirrhosis. A clinical study of treatment of their bleeding in 72 cases. Arch Surg 83:370–383

    Google Scholar 

  8. Polish E, Christie J, Cohen A et al (1962) Idiopathic presinusoidal portal hypertension (Banti’s syndrome). Ann Intern Med 56:624–627

    PubMed  CAS  Google Scholar 

  9. Basu AK, Boyer J, Bhattacharya R et al (1967) Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. I. Clinical and function studies and result of operations. II. Histopathological studies. Ind J Med Res 55:336–339

    CAS  Google Scholar 

  10. Bernard PH, Le Bail B, Cransac M et al (1995) Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol 22:495–499

    Article  PubMed  CAS  Google Scholar 

  11. Sarin SK (1989) Non-cirrhotic portal fibrosis. Gut 5:336–351

    Google Scholar 

  12. Kohno K, Ohnishi K, Omata M (1988) Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology 94:787–796

    Google Scholar 

  13. Huet PM, Guillaume E, Cote J et al (1975) Noncirrhotic presinusoidal portal hypertension associated with chronic arsenical intoxication. Gastroenterology 68:1270–1277

    PubMed  CAS  Google Scholar 

  14. Yamaguchi E, Yamanoi A, Ono T et al (2007) Experimental investigation of the role of endothelin-1 in idiopathic portal hypertension. J Gastroenterol Hepatol 22(7):1134–1140

    Article  PubMed  CAS  Google Scholar 

  15. Guha Mazumdar DN, Gupta JD, Dasgupta JD (1991) Arsenic and non-cirrhotic portal hypertension. J Hepatol 13:376

    Article  PubMed  CAS  Google Scholar 

  16. Vakili C, Farahvash MJ, Bynum TE (1992) ‘Endemic’ idiopathic portal hypertension. Report on 32 patients with noncirrhotic portal fibrosis. World J Surg 16:118–125

    Article  PubMed  CAS  Google Scholar 

  17. Rai T, Ohira H, Fukaya E et al (2004) A case of merged idiopathic portal hypertension in course of mixed connective tissue disease. Hepatol Res 30:51–55

    Article  PubMed  Google Scholar 

  18. Takagi K, Nishio S, Akimoto K et al (2006) A case of systemic sclerosis complicated by idiopathic portal hypertension: case report and literature review. Mod Rheumatol 16:183–187

    Article  PubMed  Google Scholar 

  19. Saito K, Nakanuma Y, Takegoshi K et al (1993) Nonspecific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. Hepatogastroenterology 40:163–166

    PubMed  CAS  Google Scholar 

  20. Girard M, Amiel J, Fabre M et al (2005) Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism? Am J Med Genet A 135:186–189

    PubMed  Google Scholar 

  21. Sarin SK, Malhotra V, Mehra NK et al (1987) Familial aggregation in non-cirrhotic portal fibrosis: a study of four families. Am J Gastroenterol 82:1130–1134

    PubMed  CAS  Google Scholar 

  22. Aikat BK, Bhusnurmath SR, Chhuttani PN et al (1979) The pathology of noncirrhotic portal fibrosis. Hum Pathol 10:405–418

    Article  PubMed  CAS  Google Scholar 

  23. Okuda K, Nakashima T, Okudaira M et al (1982) Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. Liver 2:176–192

    PubMed  CAS  Google Scholar 

  24. Nakanuma Y, Tsuneyama K, Ohbu M et al (2001) Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract 197:65–76

    Article  PubMed  CAS  Google Scholar 

  25. Ohbu M, Okudaira M, Watanabe K et al (1994) Histopathological study of intrahepatic aberrant vessels in cases of non-cirrhotic portal hypertension. Hepatology 20:302–308

    Article  PubMed  CAS  Google Scholar 

  26. Sarin SK, Kapoor D (2002) Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol 17(5):526–534

    Article  PubMed  CAS  Google Scholar 

  27. Hillaire S, Bonte E, Denninger MH et al (2002) Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 51(2):275–280

    Article  PubMed  CAS  Google Scholar 

  28. Okuda K (1986) Idiopathic portal hypertension. In: Thomas HC, Jones EA (eds) Recent advances in hepatology, 2nd edn. Edinburgh, Churchill Livingstone, pp 93–108

    Google Scholar 

  29. Dhiman RK, Chawla Y, Vasishta RK et al (2002) Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 17(1):1–5

    Article  Google Scholar 

  30. Okuda K, Kono K, Ohnishi K et al (1984) Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology 86:600–610

    PubMed  CAS  Google Scholar 

  31. Ramalingaswami V, Wig KL, Sama SK (1962) Cirrhosis of the liver in northern India. A clinicopathological study. Arch Intern Med 110:350–358

    PubMed  CAS  Google Scholar 

  32. Sarin SK, Sachdev G, Nanda R (1986) Follow-up of patients after variceal eradication. A comparison of patients with cirrhosis, non-cirrhotic portal fibrosis and extrahepatic obstruction. Ann Surg 202:78–82

    Article  Google Scholar 

  33. Harmanci O, Bayraktar Y (2007) Clinical characteristics of idiopathic portal hypertension. World J Gastroenterol 13(13):1906–1911

    PubMed  Google Scholar 

  34. Okuda K (1988) Idiopathic portal hypertension and protein C deficiency. Hepatology 8(5):1110–1111

    Article  Google Scholar 

  35. Ishii M, Katada Y (2003) Idiopathic portal hypertension in a systemic sclerosis patient heterozygous for factor V Leiden mutation. Rheumatol Int 23(1):44–46

    PubMed  Google Scholar 

  36. Bertina RM, Koeleman BPC, Koster T et al (1994) Mutation in blood coagulation factor associated with resistance to activated protein C. Nature 369:64–67

    Article  PubMed  CAS  Google Scholar 

  37. Dönmez Y, Kanadasi M, Tanriverdi K et al (2004) Prothrombin 20210GA and factor V Leiden mutations in patients less than 55 years old with myocardial infarction. Jpn Heart J 45(3):505–512

    Article  PubMed  Google Scholar 

  38. Bloemenkamp KW, Rosendaal FR, Helmerhorst FM et al (1995) Enhancement by factor V Leiden mutation of risk of deep vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 346:1593–1596

    Article  PubMed  CAS  Google Scholar 

  39. Rosendaal FR, Koster T, Vandenbroucke JP et al (1995) High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 86:4700–4702

    Google Scholar 

  40. Mikkola H, Syrjälä M, Rasi V et al (1994) Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 84(2):517–525

    PubMed  CAS  Google Scholar 

  41. Dong QL, Zhang C (2004) Association between the polymorphism of beta-fibrinogen gene-455G/A and ischemic stroke. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21(3):274–276

    PubMed  CAS  Google Scholar 

  42. Humphries S, Henry J, Montgomery H (1999) Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Blood Coagul Fibrin 10:S17–S21

    CAS  Google Scholar 

  43. Tàssies D, Espinosa G, Muñoz-Rodríguez FJ et al (2000) The 4G/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome. Arthritis Rheum 43:2349–2358

    Article  PubMed  Google Scholar 

  44. Stegnar M, Uhrin P, Peternel P et al (1998) The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost 79:975–979

    PubMed  CAS  Google Scholar 

  45. Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach M et al (2003) Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism: impaired fibrinolysis and early pregnancy loss. Clin Chem 49(7):1081–1086

    Article  PubMed  CAS  Google Scholar 

  46. Seguí R, Estellés A, Mira Y et al (2000) PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol 111(1):122–128

    Article  PubMed  Google Scholar 

  47. Beer JH, Pederiva S, Pontiggia L (2000) Genetics of platelet receptor single-nucleotide polymorphisms: clinical implications in thrombosis. Ann Med 32(Suppl 1):10–14

    PubMed  CAS  Google Scholar 

  48. Slowik A, Dziedzic T, Turaj W et al (2004) A2 alelle of GpIIIa gene is a risk factor for stroke caused by large-vessel disease in males. Stroke 35(7):1589–1593

    Article  PubMed  CAS  Google Scholar 

  49. den Heijer M, Koster T, Blom HJ et al (1996) Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 334:759–62

    Article  Google Scholar 

  50. van der Put NM, Gabreëls F, Stevens EM, Smeitink JA et al (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neuraltube defects? Am J Hum Genet 62:1044–1051

    Article  PubMed  Google Scholar 

  51. Weisberg I, Tran P, Christensen B et al (1998) A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64:169–172

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Dicle University Faculty of Medicine, 21280, Diyarbakir, Turkey

    Kadim Bayan, Şerif Yılmaz & Mehmet Dursun

  2. Department of Gastroenterology, Internal Medicine, Dicle University Faculty of Medicine, Diyarbakir, Turkey

    Yekta Tüzün

  3. Department of Biochemistry, Dicle University Faculty of Medicine, Diyarbakir, Turkey

    Naime Canoruc

Authors
  1. Kadim Bayan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yekta Tüzün
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Şerif Yılmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naime Canoruc
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mehmet Dursun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kadim Bayan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bayan, K., Tüzün, Y., Yılmaz, Ş. et al. Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopathic portal hypertension. J Thromb Thrombolysis 28, 57–62 (2009). https://doi.org/10.1007/s11239-008-0244-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-008-0244-8

Keywords

Search

Navigation